The guys a troll. Keeps posting about how he got burnt from old preliminary data from a cholesterol drug from last year like it has anything to do with current NYR-BO3. The company has learnt that releasing preliminary results like last time hurt the sentiment hence why are now announcing final results on each GLP study. Based off preliminary results we can extrapolate for now there are no issues but final results are due this week or next.
The company owns a whole drug class that no one can touch and the first of its kind which is so far more superior than first line FDA drugs in a 4 billion dollar market. Going to continue to rerate as safety is ticked off this quarter and we head into TBI results from Walter Reed. TBI drugs on potential and safety clearance are valued at 100 million dollar plus market caps. So exciting period for the company and 18 million market cap is pathetic
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)